Yardley, Denise A <br/><br/>
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer.  [electronic resource] 

 -  Breast cancer research and treatment  Jun 2014 
 - 725-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-014-2916-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Neoplasm Recurrence, Local--pathology<br/>Prospective Studies<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab<br/>Treatment Outcome<br/>Tumor Burden